Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Iran fires one of largest barrages in weeks ahead of Passover - 2Building an Individual Brand: Illustrations from Powerhouses
- 3Most loved Caf\u00e9 Chain: Where Do You Get Your Caffeine Fix
- 4Governments take targeted action as fuel prices hit retail
- 5Countdown begins for long-awaited Artemis II moon mission
- What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder
- What you need to know about flu treatments as cases spike across the US
- The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
- 'Harmonious' meeting between Merz, Lula despite Belém controversy
- Environmental groups urge Germany to cut oil and gas dependence
- First Alert: Light snow through this evening
- Is Iran using cryptocurrencies to circumvent sanctions?
- Tasting America: An Excursion Through Darling Cheap Food Brands
- At UN climate conference, some activists and scientists want more talk on reforming agriculture
